New Owner
Gilead Sciences - CV Therapeutics
Gilead Sciences acquires CV Therapeutics
Announced: April 17, 2009
Type: Acquisition
Disposition: Combined
Terms: Cash & Stock
Status: Complete
Amount: $ 1,390,000,000
Acquisition News
Add News| Date | Title | |
|---|---|---|
| Apr 17, 2009 | gilead.com - Gilead Sciences Completes Acquisition of CV Therapeutics |
|
Gilead Sciences Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Aug 28, 2017 |
|
$ 11,900,000,000 |
| Apr 04, 2016 |
|
Undisclosed amount |
| May 06, 2015 |
|
$ 65,000,000 |
| Jan 06, 2015 |
|
$ 470,000,000 |
| Feb 08, 2013 |
|
$ 487,600,000 |
| Nov 21, 2011 |
|
$ 11,000,000,000 |
